AKT1 and neuroblastoma: The significance of the PI3K/AKT pathway and its potential as a therapeutic target for cancer treatment have been investigated in preclinical studies of several types of human cancer, including renal cancer, lung cancer, breast cancer, glioblastoma, neuroblastoma, and HCC.